Decision Aid Efficacy in Low Risk Thyroid Cancer

Starting soon · Not applicable

Conditions studied: Differentiated Thyroid Cancer (DTC), Papillary Thyroid Microcarcinoma, Papillary Thyroid Carcinoma

In brief

Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.

Key facts

Study ID

NCT07536412

Run by

University of Maryland, Baltimore

People needed

34

Starts

2026-05-15

Expected to finish

2029-06-15

Last updated by the study team

2026-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Low-risk thyroid cancer or thyroid nodule suspicious for malignancy
• English-speaking

You may not qualify if…

• Prior consultation with surgeon regarding the thyroid nodule / cancer in question
• Cancer/nodule has high risk features (e.g. extrathyroidal extension on ultrasound)
• History of thyroid cancer
• History of thyroid surgery
• Currently pregnant (per patient report)

Where it is running

• University of Maryland, Baltimore — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.